---
title: "Therapeutics MD (TXMD.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TXMD.US/norm.md"
symbol: "TXMD.US"
name: "Therapeutics MD"
parent: "https://longbridge.com/en/quote/TXMD.US.md"
datetime: "2026-03-12T05:28:17.223Z"
locales:
  - [en](https://longbridge.com/en/quote/TXMD.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TXMD.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TXMD.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/TXMD.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/TXMD.US/norm.md)


# Therapeutics MD (TXMD.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.0100 | 0.0476 | -0.0615 | 0.0219 | -0.0536 |
| ROE | 0.73% | 8.07% | -9.40% | 1.67% | -8.28% |
| Revenue | 784000.00 | 952000.00 | 393000.00 | 667000.00 | 547000.00 |
| Net income | 152000.00 | 551000.00 | -653000.00 | 252000.00 | -609000.00 |
| Operating income | -296000.00 | -319000.00 | -783000.00 | -312000.00 | -859000.00 |
| Gross margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Net margin | 19.39% | 57.88% | -166.16% | 37.78% | -111.33% |
| Profit quality | -28.30% | -98.46% | -114.14% | -2600.00% | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 38.67M | 38.50M | 38.24M | 38.82M | 39.55M |
| Leverage | 1.41 | 1.41 | 1.43 | 1.42 | 1.46 |
| BVPS | 2.37 | 2.36 | 2.31 | 2.37 | 2.35 |
| Turnover | 0.0715 | 0.0651 | 0.0458 | 0.0429 | 0.0354 |
| Cash & STI | 7.12M | 6.07M | 5.75M | 5.06M | 5.05M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 5.51M | 5.73M | 5.95M | 6.10M | 6.30M |
| Net debt | -632000.00 | 535000.00 | 1.23M | 2.12M | 2.35M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 1.05M | 324000.00 | 686000.00 | 12000.00 | -185000.00 |
| Investing CF | - | - | - | - | - |
| Financing CF | - | - | - | - | - |
| Free CF | 12000.00 | -682375.00 | 258625.00 | -984000.00 | -829875.00 |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |